spinal fusion
-
Biologics
Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH
SCHLIEREN (ZURICH), Switzerland, Sept. 01, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences, a leader in next generation bone graft technologies, today announced…
Read More » -
Biologics
Kuros Reports Publication of MagnetOs Preclinical Data Demonstrating Superiority to Market-Leading Synthetic Bone Grafts in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Jan. 30, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced the publication of data from…
Read More » -
Spine
Inspired Spine has released an innovative study presenting the use of Porcine Cadavers as an Alternative to Human Cadavers for Teaching Minimally Invasive Spinal Fusion
BURNSVILLE, Minn., Dec. 20, 2019 /PRNewswire/ — Inspired Spine has released an innovative study presenting the use of Porcine Cadavers as an Alternative…
Read More » -
Hospitals
More Than $20 Million Paid By Hospital To Settle Fraud Case Filed By JGL And Its Whistleblower Clients
GREENBELT, Md., Oct. 29, 2019 /PRNewswire/ — A whistleblower case alleging kickbacks and unnecessary spine surgeries has been settled by Sanford Health in South…
Read More » -
Biologics
Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion
Kuros to conduct Phase 2a trial in spinal fusion, comparing Fibrin-PTH to autograftPrimary endpoint is radiographic interbody fusion at 12 months SCHLIEREN…
Read More » -
Biologics
Celling Spine Acquires Assets of Link Spine to Further Develop and Promote a Cell Centric Spine Platform
AUSTIN, Texas, July 1, 2019 /PRNewswire/ — Celling Spine (“Celling”) a subsidiary of Celling Biosciences, based in Austin, Texas, acquired all the assets of…
Read More » -
Spine
New Study Finds Plasmapore®XP Surface Enhancement Demonstrates Enhanced Osseointegrative Properties
CENTER VALLEY, Pa., Jan. 28, 2019 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the publication of “Porous titanium-coated polyetheretherketone implants exhibit an…
Read More » -
Biologics
Kuros Reports Publication of MagnetOs Data Demonstrating Equivalence to Autologous Bone in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced the publication of data from…
Read More » -
Financial
Global Spine Market to Reach $18 Billion by 2023 According to New Analysis by iData Research
September 13, 2018 VANCOUVER, British Columbia–(BUSINESS WIRE)–According to a new series of reports by iData Research, the global spine market…
Read More » -
Biologics
Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion
March 28, 2017 BOISE, Idaho–(BUSINESS WIRE)–Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal…
Read More » -
Spine
Amedica and Celling Biosciences to Collaborate on Biologically Enhanced Spinal Fusion Devices
Amedica’s Silicon Nitride Performed 400% Better Than PEEK in Recent Cell Adhesion Study SALT LAKE CITY, March 02, 2016 (GLOBE NEWSWIRE) — Amedica…
Read More » -
Spine
New spinal fusion system going to human trials in Australia: 5 key notes
By Laura Dyrda Researchers at the University of New South Wales in Australia are developing and testing the Thru-Fuze device…
Read More » -
Spine
5 things to know about short-term morbidity for neuromuscular scoliosis surgery patients
By Laura Dyrda A new study published in Spine examined the risk factors for short-term morbidity after posterior spinal fusion…
Read More » -
Spine
Does spinal fusion union rate make a difference? 5 things to know
By Laura Dyrda A new study published in Spine examines fusion rate for patients undergoing spinal fusion with rhBMP-2 or fusion with iliac crest…
Read More »